DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Bogetto F, Bellino S, Vaschetto P, Ziero S.
Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
Psychiatry Res 2000; 96: 91-98
We do not assume any responsibility for the contents of the web pages of other providers.